Work

Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging

Year: 2026
Type: article
Abstract: BACKGROUND: Paediatric sedation for magnetic resonance imaging presents significant challenges. To facilitate this, our department decided to implement paediatric sedation with intranasal dexmedetomidine for children requiring a scan. We aim to summarise lessons learnt from implementation of intranasal dexmedetomidine, comparing time consumption and effectiveness. METHODS: We conducted a prospective observational study. Data from children sedated with intranasal dexmedetomidine 4 μg/kg (n = 51) were collected prospectively and compared with historical controls (n = 100) collected from children previously anaesthetized with either sevoflurane or propofol. RESULTS: Sedation with intranasal dexmedetomidine resulted in a longer hospital stay (214 min vs. 133 min [67.94-94.74]), longer time to sufficient sedation (60 min vs. 26 min [29.31, 38.68]) and longer time in the post-operative unit (112 min vs. 64, 48 min [36.11, 60, 80]). Of children sedated with dexmedetomidine, 75% were cooperative with the intranasal administration of the medicine and 37% were successfully sedated with dexmedetomidine as the sole sedative. In the historical controls, 43% of patients required airway management compared to 1.9% in the dexmedetomidine group [0.00, 0.19]. In the control group, 20% had post-sedation agitation compared to none in the dexmedetomidine group. No serious bradycardia or desaturation was registered in either group. CONCLUSION: Paediatric sedation with intranasal dexmedetomidine as the sole medicament for magnetic resonance imaging is more time-consuming compared to sevoflurane and propofol. Sedation with intranasal dexmedetomidine has a relatively low success rate but is without serious adverse events. EDITORIAL COMMENT: This single center case-control study with prospective datacollection for the case group, intranasal dexmedetomidine and comparison with a historical non-dexmedetomidine sedation group described multiple possible clinical advantages with intranasal dexmedetomidine administration as it was done here.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,430
OpenAlex ID: W7237260239
FWCI:
Cites: 33
Cited by:
Related to: 10